Tate & Lyle (TATE) accepts £2.7 billion takeover offer from US rival Ingredion
Tate & Lyle Plc shares advanced on Monday after the company accepted a £2.7 billion takeover offer from US rival Ingredion. The UK-based ingredients firm is trading at 552p, up 12.3% from its previous close of 491p.
The acquisition values Tate & Lyle at 615p per share, comprising 595p in cash and up to 20p in dividends. This represents a significant premium to recent trading prices and is viewed as an attractive opportunity for shareholders, despite the company's recent "disappointing" results. The deal will allow Ingredion to expand its specialty ingredients division, creating a larger entity in the food and beverage ingredients sector.
The move follows an earlier announcement on June 8, 2026, that Tate & Lyle's directors backed Ingredion's acquisition offer. The current share price reflects investor reaction to the formal acceptance, with the stock clawing back some of the previous week's decline, which saw it fall to 491.40p on Friday, June 5.
Why Ingredion's Takeover Offer Sweetens Tate & Lyle's Shares
Tate & Lyle is a UK-based ingredients firm, operating primarily in the food and beverage sector. They develop and supply a wide range of specialty ingredients, from sweeteners and texturants to fibres, which food manufacturers use to improve the taste, texture, and nutritional profile of their products. Essentially, they are the behind-the-scenes innovators helping companies create everything from healthier yoghurts to more appealing soft drinks, making their money by providing these essential components to other businesses.
The primary driver behind today's share price movement is the formal acceptance of a £2.7 billion takeover offer from US rival Ingredion. Tate & Lyle's board had previously backed the offer, announced on 8 June 2026, but the formal acceptance confirms the deal. Ingredion's bid values Tate & Lyle at 615p per share, comprising 595p in cash and up to 20p in dividends, which represents a significant premium over recent trading prices and is designed to expand Ingredion's own specialty ingredients division.
This formal acceptance of the acquisition offer has directly propelled Tate & Lyle's shares. The stock is currently trading at 552p, marking a substantial 12.3% increase from its previous close of 491p.
Think of it like a rare, vintage collectable item that has been quietly sitting in a shop window, perhaps not getting the attention it deserves. Then, a specialist collector comes along, recognises its true value and potential, and makes a public, generous offer to buy it. The moment the shop owner agrees to that offer, the market's perception of that item's worth immediately jumps, reflecting the premium the specialist is willing to pay.
Tate & Lyle
Tate & Lyle plc (TATE), a stalwart in the consumer defensive sector, specialises in providing essential ingredients and solutions to the food, beverage, and other industrial sectors globally. Operating through its Food & Beverage Solutions, Sucralose, and Primary Products segments, the company offers a diverse portfolio including texturants, nutritive sweeteners such as high fructose corn syrup and dextrose, and health and wellness ingredients. Beyond food applications, Tate & Lyle supplies industrial starches for paper and packaging, acidulants like citric acid, and commodities including corn gluten feed and meal for animal nutrition, alongside corn oil and ethanol. The firm also manages treasury and insurance operations, complemented by dedicated research and development services. Established in 1903, Tate & Lyle plc is headquartered in London, United Kingdom.